PREVALENCE OF DRUG RESISTANT HIV STRAINS IN HIV-INFECTED PATIENTS OF REPRODUCTIVE AGE

N. Babii
SI "L.Gromashevsky Institute of epidemiology and infectious diseases of NAMSU", Kyiv, Ukraine

Abstract


The prevalence of drug resistant HIV strains among HIV-positive reproductive aged persons with ineffective antiretroviral therapy (ART) was assessed. The prevalence of drug resistant strains of HIV was 73.8% in the group of women and 89.29% in the group of men (totally in 80.0% of patients). In the spectrum of drug resistance mutations (DRMs) the most prevalent mutation associated with high-level resistance to nucleoside reverse transcriptase inhibitors was substitution M184V (80.36%); in addition, the high prevalence of K65R (26.79%) was indicated. The most common mutations causing a high-level resistance to nonnucleoside reverse transcriptase inhibitors were G190S/A (57.14%), Y181C (37.50%), K101E (33.93%). The DRMs to protease inhibitors were indicated with significantly less frequent (5.36%).

Keywords


HIV, drug resistant mutations, antiretroviral therapy

Full Text:

PDF

References


Аналіз молекулярних особливостей українських ізолятів ВІЛ-1/ Пукіш Н.С., Щербінська А.М., Бабій Н.О., Поліщук В.П. // Біополімери і клітина. – 2009. – Т.25, №1. – С. 50 – 55.

Дементьева Н.Е., Н.В.Сизова, З.Н.Лисицина. Анализ субтипов и фармакорезистентных вариантов ВИЧ, циркулирующих среди ВИЧинфицированных пациентов Санкт-Петербурга / ВИЧ-инфекция и иммуносупрессии. – 2011. – Том 3, №4. – C.34 – 43.

Парфенова О.В., Пекшева О.Ю., Зайцева Н.Н. Мутации, определяющие резистентность ВИЧ к антиретровирусной терапии в Приволжском Федеральном округе в 2008 – 2012гг. Медицинский альманах. – 2013. – №2(26) – С.79-82.

Пукіш Н.С., Щербінська А.М., Будзанівська І.Г., Поліщук В.П. Філогенетичний аналіз українських ізолятів ВІЛ-1 / Доповіді Національної академії наук України. – 2009. – №8. – С.158 – 162.

А.Г.Рахманова, Н.Г.Захарова, С.Э.Тропов Формирование резистентности к высокоактивной антиретровирусной терапии у ВИЧинфицированных пациентов /ВИЧ-инфекция и иммуносупрессии. – 2012. – Том 4, №2. – C.55 – 63.

Avila-Ríos S., García-Morales C., Tapia-Trejo D.. HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy / PLoS One. – 2015. – Vol.10. – 17p.

Hawkins C.A., Chaplin B., Idoko J. Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria / J. AIDS. – 2009. – Vol. 52(2). – P.228 – 234.

Joly V., Descamps D., Peytavin G. Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs /Antimicrob. Agents Chemother. – 2004. – Vol.48. – P.172–175.

HIV Drug Resistance database of Stanford Unievrsity/ http://hivdb.stanford.edu/).

R. W. Shafer, S.-Y. Rhee, D.Pillay HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance / AIDS. – 2007. – Vol.21. – P.215 – 223.

De Luca A., Giambenedetto S.D. Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine / J. Infect. Dis. – 2007. – Vol. 196, № 11. – P. 1645–1653.

Molecular Epidemiology of HIV Type 1 in Ukraine: Birthplace of an Epidemic / Saad M.D., Scherbinskaya A.M., Nadai Y. [at al] // AIDS Research and Human Retroviruses. – 2006. – Vol. 22, №8. – Р.709–714.

Thirunavukarasu D., Udhaya V., Syed Iqbal H., Umaarasu T. Patterns of HIV-1 Drug-Resistance Mutations among Patients Failing First-Line Antiretroviral Treatment in South India /J. Int. Assoc. Provid. AIDS Care. – 2015. [Epub ahead of print].

Vermeiren H., Van Craenenbroeck E., Alen P. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling/ J Virol Methods. – 2007 – Vol.145. – P.47 – 55.

Booth C.L., Garcia-Diaz A.M., Youle M.S. Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection / J. of Antimicrobial Chemotherapy. – 2007. – Vol.59 (3). – P.517–524.

Cozzi-Lepri А., Ruiz L., Loveday C.Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy. Antiviral Therapy. – 2005. – Vol. 10(7). – P.791–802.


Refbacks

  • There are currently no refbacks.